(±)-13-Hydroxy-10-oxo-trans-11-octadecenoic acid (13-HOA) is one of the lipoxygenase metabolites of linoleic acid (LA) from corn germ. Recently, we reported that this metabolite suppressed the expression of lipopolysaccharide-induced proinflammatory genes in murine macrophages by disrupting mitogen-activated protein kinases and Akt pathways. In this study, we investigated the inhibitory effects of 13-HOA on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in ears and skin, as well as tumor promotion in female ICR mice. Pretreatment with 13-HOA (1600 nmol) inhibited ear edema formation by 95% (P < 0.05) in an inflammation test and reduced tumor incidence and the number of tumors per mouse by 40 and 64% (P < 0.05 each), respectively, in a two-stage skin carcinogenesis model. Histological examinations revealed that it decreased epidermal thickness, the number of infiltrated leukocytes and cell proliferation index. Furthermore, 13-HOA (8-40 mM) suppressed TPAinduced anchorage-independent growth of JB6 mouse epidermal cells by 70-100%, whereas LA was virtually inactive. 13-HOA (40 mM) inhibited TPA-induced activator protein-1 transactivation but not extracellular signal-regulated kinase1/2 activation. Interestingly, 13-HOA (40 mM and 1600 nmol in JB6 cells and mouse skin, respectively) induced expression of programmed cell death 4 (Pdcd4), a novel tumor suppressor protein. To our knowledge, this is the first report of a food factor that is able to induce Pdcd4 expression. Collectively, our results indicate that 13-HOA may be a novel anti-inflammatory and antitumor chemopreventive agent with a unique mode of action.
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Introduction
A two-stage mouse skin carcinogenesis model is useful for understanding the multistage nature of human neoplasia and ideal for studying a variety of biochemical alternations, changes in cellular functions and histological changes that occur during the different stages of chemical carcinogenesis (1) (2) (3) . On the other hand, there is a large body of evidence showing that inflammation plays important roles in the promotion and progression of skin tumorigenesis (4) . That report also noted that the essential contribution of inflammation to tumor development and progression is supported from observations indicating that tumor promotion originates from exposure of initiated cells to chemical irritants such as 12-O-tetradecanoylphorbol-13-acetate (TPA). TPA activates transcription factors including activator protein-1 (AP-1) and nuclear factor-jB by upregulation of mitogen-activated protein kinase (MAPK) and Akt (protein kinase B) activities in mouse skin, which have a partial correlation with signaling molecules that participate in lipopolysaccharide (LPS)-treated macrophages (5) (6) (7) .
The mouse JB6 epidermal variant cell system, which includes transformation-sensitive (Pþ) and transformation-resistant (PÀ) cells, is a valuable cell culture model that demonstrates a number of molecular events and pathways involved in the tumor promotion stage of mouse skin carcinogenesis (5, 6 ). This unique cell line responds irreversibly to tumor promoters and growth factors to exhibit tumor phenotypes, including anchorage-independent growth in soft agar (5) . Similar to the mouse skin model, TPA activates AP-1 and upstream signaling molecules in JB6 Pþ cells, such as MAPKs and Akt (7, 8) .
Programmed cell death 4 (Pdcd4), also known as MA3 (9) and DUG (10), was recently identified as a novel tumor suppressor. Differential display of the messenger RNA (mRNA) expression profile in JB6 Pþ and PÀ cells showed pdcd4 to be preferentially expressed in JB6 PÀ cells, whereas a reduction of Pdcd4 in JB6 PÀ cells by an antisense approach resulted in acquisition of transformation responses (11) . Conversely, stable overexpression of Pdcd4 in JB6 Pþ cells produced a transformation-resistant phenotype (12) . Moreover, pdcd4 transgenic mice are resistant to skin tumorigenesis and tumor progression (13) . These findings suggest that Pdcd4 is a novel suppressor of tumor promoter-induced transformation. Thus, induction or production of this molecule may be a promising strategy for cancer prevention; however, there are few known compounds capable of inducing Pdcd4 mRNA and protein (14, 15) .
(±)-13-Hydroxy-10-oxo-trans-11-octadecenoic acid (13-HOA) is one of the lipoxygenase metabolites of linoleic acid (LA) found in corn germ, in which LA is oxidized enzymatically or spontaneously to 13-HOA ( Figure 1 ) (16) . It was previously reported that 13-HOA showed toxicity toward several cancer cell lines via an unknown mechanism (17) . Recently, we reported that 13-HOA significantly inhibited activation of both MAPKs and Akt and reduced the expression of proinflammatory genes in RAW 264.7 murine macrophages (18) . Together, these findings suggest that 13-HOA is an effective chemopreventive agent, though there are no known reports of its in vivo efficacy.
In the present study, we determined whether 13-HOA inhibits TPAinduced inflammatory and tumor promotion using mouse ear inflammation and 7,12-dimethylbenz(a)anthracene (DMBA)/TPA-induced two-stage mouse skin carcinogenesis models and TPA-induced anchorage-independent growth in JB6 Pþ cells. In addition, we assessed the effects of 13-HOA on mRNA and protein expression of pdcd4 in JB6 Pþ cells and mouse skin.
Materials and methods

Animals and cells
Female ICR mice were purchased from Japan SLC (Shizuoka, Japan) at 5-6 weeks of age and maintained according to the Guidelines for the Regulation of Animals, provided by the Animal Experimentation Committee of Kyoto University. All animals were housed under controlled conditions of humidity (60 ± 5%), lighting (12 h light cycle) and temperature (24 ± 2°C). Mouse epidermal JB6 Pþ (Cl 41-5a) cells were purchased from American Type Culture Collection (Manassas, VA). JB6 Pþ cells and JB6 (P þ11 ) cells transfected stably with Abbreviations: AP-1, activator protein-1; DMBA, 7,12-dimethylbenz(a) anthracene; DMEM, Dulbecco's modified eagle medium; DMSO, dimethyl sulfoxide; EMEM, Eagle's minimum essential medium; ERK, extracellular signal-regulated kinase; FBS, fetal bovine serum; Fra-1, fos-like region antigen; 13-HOA, (±)-13-hydroxy-10-oxo-trans-11-octadecenoic acid; JNK, c-Jun N-terminal kinase; LA, linoleic acid; LPS, lipopolysaccharide; MAPK, mitogen-activated protein kinase; miR-21, microRNA-21; mRNA, messenger RNA; Myb, v-myb myeloblastosis viral oncogene homolog; PCNA, proliferating cell nuclear antigen; PCR, polymerase chain reaction; Pdcd4, programmed cell death 4; TPA, 12-O-tetradecanoylphorbol-13-acetate.
an AP-1-luciferase reporter (19) were grown in Dulbecco's modified eagle medium (DMEM) supplemented with 5% heat-inactivated fetal bovine serum (FBS), penicillin (100 U/ml) and streptomycin (100 lg/ml) or Eagle's minimum essential medium (EMEM) supplemented with 5% heat-inactivated fetal FBS, penicillin (100 U/ml), streptomycin (100 lg/ml) and G418 (600 lg/ml), at 37°C under a humidified atmosphere of 95% air and 5% CO 2 .
Chemicals 13-HOA was purified as previously reported (.95% purity) (16) . DMEM, EMEM and FBS were purchased from Invitrogen (Carlsbad, CA). Antibodies were obtained from the following sources: rabbit anti-phospho-extracellular signal-regulated kinase (ERK)1/2, rabbit anti-ERK1/2 antibody and horseradish peroxidase-conjugated anti-rabbit IgG from Cell Signaling Technology (Beverly, MA); goat anti b-actin antibody from Santa Cruz Biotechnology (Santa Cruz, CA); mouse anti-a-tubulin antibody from Oncogene (San Diego, CA); horseradish peroxidase-conjugated anti-goat IgG and anti-mouse IgG from Dako (Glostrup, Denmark) and G418 from Sigma-Aldrich (St Louis, MO). Anti-Pdcd4 antibody was generated as previously reported (12) . All other chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan), unless otherwise specified.
Mouse ear inflammation test
The inflammation assay was performed as previously reported (20) . Briefly, ICR mice at 6-7 weeks old were divided into five groups (n 5 5 per group). Each mouse had 0, 160 or 1600 nmol of 13-HOA or 1600 nmol of LA dissolved in 20 ll of acetone applied to the left ear, whereas the other ear received the same volume of the vehicle alone. After 20 min, 1.6 nmol of TPA dissolved in 20 ll acetone was applied to both ears. After 6 h, ear punch biopsies (6 mm diameter) were obtained and weighed to determine the increase in ear weight.
Two-stage mouse skin carcinogenesis test
The antitumor-promoting activities of 13-HOA were examined using a standard initiation-promotion protocol with DMBA and TPA as previously reported, with some modifications (21) . The back of each 7-week-old female ICR mouse was shaved with a surgical clipper 2 days before initiation, then DMBA (200 nmol) was dissolved in 200 ll of acetone and applied onto the back of each mouse. One week later, the mice were exposed to a topical application of 0, 160 or 1600 nmol of 13-HOA (n 5 25 per group) and 160 or 1600 nmol of LA (n 5 15 per group) dissolved in 200 ll acetone 30 min before each TPA or acetone treatment (1.6 nmol), which was done twice a week for 20 weeks. Antitumor-promoting activities were evaluated by the incidence of tumor-bearing mice, the number of tumors (.1 mm in diameter) per mouse and average tumor diameter, which was determined as the average diameter of all papillomas on each mouse.
Histopathological analysis
After week 20 of the two-stage mouse skin carcinogenesis experiment, the mice were euthanized and then tissue biopsies were obtained and subjected to histopathological evaluations. Histopathological examinations were performed using biopsy sections randomly chosen from 12 mice in the none, acetone, TPA-only and DMBA-only groups and from 18 mice in the DMBA-TPA, þ160 nmol 13-HOA and þ1600 nmol 13-HOA groups. Formalinfixed and paraffin-embedded skin sections were subjected to deparaffinization and dehydration prior to quenching of endogenous peroxidase activity (1.5% H 2 O 2 in absolute methanol for 20 min). An antigen-unmarking step was done by placing the slides in a pressure cooker containing 0.01 M sodium citrate (pH 6.0) for 10 min. The sections were incubated for 60 min with the primary mouse anti-rat proliferating cell nuclear antigen (PCNA) monoclonal antibody (Clone PC-10, DakoCytomation, Glostrup, Denmark, Cat no. M0879) at a dilution of 1:1500 in 10% goat serum. The secondary antibody, biotinylated goat anti-mouse IgG (Cat no. BA-2000, Vector Laboratories, Burlingame, CA), was applied for 30 min in a 1:500 dilution. Slides were processed using Vectastain Elite ABC reatent (Vector Laboratories) with diaminobenzidine as the substrate. Sections were counter stained with hematoxylin (Merck Ltd, Tokyo, Japan). All histological examinations were done by a single pathologist (T.T.) in a blind fashion.
Cell viability
Cell viability was measured using a Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto, Japan) according to the manufacturer's instructions. JB6 Pþ cells at a density of 3 Â 10 4 cells per well were cultured in 96-well plates in DMEM with 5% FBS and then incubated in a CO 2 incubator for 12 h. The cells were rinsed with phosphate-buffered saline and the medium was exchanged with DMEM with 10% FBS containing 0.25% dimethyl sulfoxide (DMSO) as the vehicle, 13-HOA, NS-398 cyclooxygenase-2 inhibitor or LA in DMSO, followed by a 30 min incubation. Ethanol (0.15%) as a vehicle or 30 nM of TPA was added to each well. After treatment for 24 h, Cell Counting Kit-8 (1%) was added and incubated for 2 h at 37°C. Absorbance in each well was determined at 450 nm (reference 650 nm) using a microplate reader (Multiskan JX Ver. 1.1, Thermo Labosystems, Helsinki, Finland). Each experiment was performed in triplicate.
Anchorage-independent transformation test
The effects of 13-HOA on TPA-induced cell transformation in JB6 Pþ cells were examined using an anchorage-independent transformation assay; the top agar was 0.33% and the bottom agar was 0.5% according to the procedure described previously (22) . Experiments were performed in six-well plates, in which 3 Â 10 3 cells were suspended in 1 ml of 0.33% agar medium, with 4 ml of 0.5% agar medium poured on top. The base agar and that poured on top consisted of DMEM (10% FBS), Bacto Agar (Difco Labs, Detroit, MI) and 13-HOA, NS-398, LA or DMSO (vehicle), along with TPA or ethanol (vehicle). The cells were preincubated with each test sample for 30 min and then incubated for 14 days at 37°C in a CO 2 incubator, with colonies .100 lm in diameter counted. None of the test samples showed notable cytotoxicity for 24 h at the various concentrations. Each experiment was done in triplicate.
Luciferase assay for AP-1-dependent transactivation JB6 P þ11 cells (4 Â 10 4 ) were seeded in 24-well plates in EMEM with 5% FBS for 24 h. The cells were then serum starved in EMEM with 0.1% FBS for 24 h and treated with or without 13-HOA (40 lM) for 30 min before the cells were exposed to TPA (30 nM). The luciferase assay was conducted using a DualLuciferase TM Reportor Assay System (Promega, Madison, WI) by slight modification of the manufacturer's protocol. Briefly, after TPA treatment for 12 h, the cells were lysed with Passive Lysis Buffer and the luciferase activity was measured by a luminometer (Lumat LB9507; PerkinElmer, Boston, MA). AP-1 activity was expressed as fold induction relative to the control cells without TPA treatment. were seeded into 60 mm dishes in DMEM with 5% FBS and then incubated in a CO 2 incubator for 12 h. The cells were rinsed with phosphate-buffered saline and the medium was exchanged with DMEM (10% FBS) containing 13-HOA, NS-398, LA or 0.25% DMSO and incubated for 30 min. Next, the cells were treated with 30 nM of TPA for the indicated hours and then the cells were lysed with lysis buffer [protease inhibitor, phosphatase inhibitor (Sigma-Aldrich), 10 mM Tris (pH 7.4), 1% sodium dodecyl sulfate and 1 mM sodium vanadate]. The back of each 7-week-old female ICR mouse was shaved with a surgical clipper before acetone or 13-HOA (1600 nmol dissolved in 200 ll acetone) treatment and then TPA (8 nmol) was dissolved in 200 ll acetone and applied onto the back of each mouse, and the mice were killed by cervical dislocation 6 h later. For the isolation of epidermal protein from mouse skin, fat and dermis were removed on ice, and the collected epidermis was lysed with lysis buffer as above. Lysates from both JB6 Pþ cells and mouse skin were sonicated and centrifuged at 15 000 r.p.m. for 5 min. Supernatant was collected and total protein concentration was quantified using a Bio Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA) and standardized with c-globulin as the reference.
Western blot analysis
These lysate samples were denatured in sample buffer containing sodium dodecyl sulfate and mercaptoethanol. An equal amount of protein (20 lg) was loaded for sodium dodecyl sulfate gel electrophoresis and then the samples were electro-transferred to Immobilon-P membranes (Millipore, MA). The transferred protein-bound membranes were blotted with each primary and secondary antibody and then visualized using enhanced chemiluminescence reagents (GE Healthcare UK Ltd, Buckinghamshire, UK). The intensity of each band was analyzed using Scion Image 0.4.0.3 (Scion Corporation, Frederick, MD).
Reverse transcription-polymerase chain reaction JB6 Pþ cells (1 Â 10 6 ) were seeded into 60 mm dishes in DMEM with 5% FBS and then incubated in a CO 2 incubator for 12 h. The cells were rinsed with phosphate-buffered saline and the medium was exchanged with DMEM with 10% FBS containing the vehicle, DMSO (0.25%), 13-HOA (1.6, 8 or 40 lM), NS-398 (100 lM) or LA (100 lM). After the indicated hours, total RNA was isolated from the cells using TRIzol Reagent (Invitrogen) according to the manufacturer's protocol. One microgram of total RNA was then added to a mixture of MgCl 2 (Ambion, Austin, TX), 10Â polymerase chain reaction (PCR) buffer, deoxynucleoside triphosphate mixture, avian myeloblastosis virus reverse transcriptase (5 U/ll), ribonuclease inhibitor and oligo dT primer (Takara, Kyoto, Japan) in a total volume of 19 ll. Each tube was placed in a thermal cycler (PTC-0100; MJ Research, Watertown, MA) and heated as follows: 10 min at 30°C, 30 min at 55°C, 5 min at 99°C and 5 min at 5°C. Next, 1 ll each of pdcd4 and cyclophilin complementary DNA were amplified with 0.5 ll of each primer (20 lM, Proligo, Kyoto, Japan) and a mixture of 10Â PCR buffer, deoxynucleoside triphosphate mixture, MgCl 2 , Taq DNA polymerase (5 U/ll) (Takara) and nuclease-free water. The primers used and PCR conditions were as follows: pdcd4 (5#-TAATCAgTgCAAgCgAAATTAAggAA-3# and 5#-CCTTTCCCAgATCTggACCgCCTATC-3#), 27 cycles at 94°C for 15 s, 55°C for 30 s and 72°C for 45 s and cyclophilin (5#-gCCAggACCTgTATgCTTCA-3# and 5#-TTgggTCgCgTCTCgTTCgA-3#), 19 cycles at 95°C for 30 s, 56°C for 30 s and 72°C for 1 min. Amplified DNA was separated by agarose gel electrophoresis. Image analysis was performed using Scion Image 0.4.0.3. No PCR saturation was confirmed by titrating each complementary DNA amount (data not shown).
Statistical analysis
Data are shown as the mean ± SD from more than three independent experiments and were evaluated by Student's t-test or a v 2 -test. Differences were considered statistically significant at the P , 0.05 level.
Results
Effects of 13-HOA on TPA-induced edema formation in ICR mice ears First, we examined the in vivo anti-inflammatory activities of 13-HOA using an acute edema formation model, in which TPA was topically applied onto the ears of ICR mice. As shown in Figure 2A , topical application of 13-HOA (160-1600 nmol), 20 min prior to TPA stimulation, significantly inhibited TPA-induced ear edema formation in a dose-dependent manner (P , 0.05, at a dose of 1600 nmol), whereas LA, the biosynthetic precursor of 13-HOA, was inactive even at a high dose.
Effects of 13-HOA on tumor promotion in ICR mice
We then examined the inhibitory effects of a topical application of 13-HOA twice a week for 20 weeks on tumor formation in DMBA (200 nmol)-initiated and TPA (1.6 nmol)-promoted mouse skin. One week following DMBA initiation, the dorsal skin of the mice was exposed to TPA in the presence or absence of 13-HOA or LA (160 and 1600 nmol each). No tumors were developed in any of the mice in the none, acetone, DMBA-only and TPA-only groups (n 5 25 in each group) (data not shown). The results showed that treatment of the animals with 13-HOA decreased tumor incidence by 40% (P , 0.05) at a dose of 1600 nmol as well as the number of tumors per mouse in a dosedependent manner (51-65% inhibition, P , 0.05) (Figure 2B-D) . LA did not inhibit tumor incidence or size at both doses (160 and 1600 nmol), and there were no differences in regard to tumor diameter among the groups. The mice were euthanized after the assays and The mice were treated with acetone, 13-HOA (160 or 1600 nmol) or LA (160 or 1600 nmol) 40 min prior to each TPA treatment. The antitumor promotion activity of 13-HOA was evaluated by tumor incidence (B), the number of tumors per mouse (C) and tumor diameter (D). None of the mice in the none, acetone, TPA-only and DMBA-only groups developed tumors. To determine significant differences, a v 2 -test was used for tumor incidence, whereas Student's t-test was used for both the number of tumors per mouse and tumor diameters. Antitumor-promoting effects of linoleic acid metabolite skin samples were analyzed by histological examinations. Application of DMBA-TPA to mouse skin resulted in a significant increase in epidermal thickness ( Figure 3A ) and number of infiltrated leukocytes ( Figure 3B ), as well as induction of the epidermal proliferative marker PCNA ( Figure 3C and D) by 1.4-, 3.6-and 2.8-fold as compared with the vehicle (P , 0.001). Of interest, 13-HOA at a dose of 1600 nmol significantly suppressed the increases in epidermal thickness by 28% (P , 0.001), number of infiltrated leukocytes by 76% (P , 0.001) and induction of PCNA by 59% (P , 0.001) (Figure 3A-D) . Even at the lowest dose (160 nmol), 13-HOA significantly reduced the number of leukocytes and induction of PCNA by 41% (P , 0.001) and 38% (P , 0.001), respectively ( Figure 3B-D) . The PCNA score for the DMBA-only group tended to be higher than that for the non-treated control, which was inconsistent with our other preliminary results (T.Tanaka and A.Murakami, unpublished data). At this moment, we have no clear explanation for this discrepancy, though other proliferation assays (e.g. Ki-67) might resolve the contradiction.
13-HOA inhibited TPA-induced transformation of JB6 Pþ cells
Subsequently, the effects of 13-HOA on TPA-induced transformation of JB6 Pþ cells were evaluated. HOA (40 lM), NS-398 (100 lM) and LA (100 lM) did not significantly affect cell viability after 24 h incubation or the rate of spontaneous transformation after 14 days. Vehicle-treated control cells had 11.0 ± 10.2 anchorage-independent colonies/dish after 14 days, whereas the addition of TPA increased the number by 15.8-fold (P , 0.001) ( Figure 4A ). 13-HOA at 8 and 40 lM decreased the relative rate of TPA-induced colony formation by 70 and 100%, respectively (P , 0.001). In addition, NS-398, used as a positive control (23), at 40 and 100 lM inhibited the rate by 80-100% (P , 0.001), whereas LA was inactive, even at a concentration of 100 lM.
13-HOA attenuated TPA-induced AP-1 transactivation but not ERK1/ 2 phosphorylation Since 13-HOA markedly inhibited TPA-induced ear inflammation, skin tumor promotion and in vitro transformation, we examined its effects on AP-1 transactivation and an MAPK pathway to address underlying molecular mechanisms. ERK1/2 have been reported to be the most important protein kinase of the MAPK family, and previous studies have suggested that resultant AP-1 transactivation is required for TPA-induced JB6 Pþ cell transformation (7, 24, 25) .
As shown in Figure 4B , TPA-treated JB6 P þ11 cells increased AP-1 transactivation level by 2.7-fold at 12 h (P , 0.005), and pretreatment with 13-HOA (40 lM) for 30 min (P , 0.005) and NS-398 Fig. 3 . After week 20 of the two-stage mouse skin carcinogenesis experiment, randomly selected biopsy samples from 12 mice in the none, acetone, TPA-only and DMBA-only groups and from 18 mice in the DMBA-TPA, þ160 nmol 13-HOA and þ1600 nmol 13-HOA groups were subjected to histopathological analysis to determine epidermal thickness (A), numbers of infiltrated leukocytes (B) and PCNA-labeling index (C and D). Representative histological results of mouse skin from each group after staining with hematoxylin and eosin (HE; original magnification Â10), and PCNA immunohistochemistry results (original magnification Â20) are shown in (D). Student's t-test was used to determine significant differences.
a P , 0.001 versus acetone, b P , 0.001 versus DMBA-TPA.
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(100 lM) also suppressed TPA-induced AP-1 transactivation by 31% (P , 0.05). However, both 13-HOA and LA did not affect TPAupregulated ERK1/2 phosphorylation, whereas NS-398 slightly potentiated it ( Figure 4C ).
13-HOA induced pdcd4 JB6 Pþ cells and mouse skin
The above results led us to explore novel molecules associated with tumor promotion. Expression of the novel tumor suppressor Pdcd4 was shown to suppress TPA-mediated tumor promotion in mouse skin and transformation of JB6 cell lines via inhibition of AP-1 mediated transcription (12, 13, 26) . On the other hand, Pdcd4 had no effect on the phosphorylation of ERK1/2 (27, 28) . For these reasons, we hypothesized that the effects of 13-HOA on TPA-induced inflammation, tumor promotion and transformation may be related to induction of Pdcd4. To test this hypothesis, we investigated the time course (0-9 h) of pdcd4 mRNA expression in JB6 Pþ cells treated with the vehicle or 13-HOA (40 lM), in the presence or absence of TPA ( Figure 5A ). 13-HOA was found to transiently increase the level of pdcd4 mRNA expression, which reached a maximum after 6 h. Then, 13-HOA treatment for 6 h induced it by 2.1-fold (P , 0.05) without TPA and by 2.5-fold (P , 0.05) with TPA. Although NS-398 (100 lM) and 13-HOA (8 lM) also tended to upregulate pdcd4 mRNA, the increase was not statistically significant, whereas 13-HOA (1.6 lM) and LA (100 lM) had no effects (data not shown).
Of note, treatment with 13-HOA for 6 h restored TPA-decreased Pdcd4 protein in JB6 Pþ cells (P , 0.05) ( Figure 5B ). Neither NS-398 (100 lM) nor LA (100 lM) induced Pdcd4 protein (data not shown). Topical application of TPA (8 nmol) to ICR mouse skin significantly decreased Pdcd4 protein expression at 6 h (P , 0.05), day incubation in a CO 2 incubator at 37°C, the number of TPA-induced anchorage-independent colonies was 174.5 ± 13.6 per 3000 cells. Each bar represents the mean obtained from triplicate dishes. Treatment with the compounds for 24 h did not affect cellular viability. Each value is the mean of triplicate wells ± SD. Student's t-test was used to determine significant differences. a P , 0.001 versus DMSO, b P , 0.001 versus TPA þ DMSO. (B) For report gene assay, AP-1-luciferase reporter plasmid stable transfectant JB6 P þ11 cells were cultured with DMSO, 13-HOA (40 lM) or NS-398 (100 lM) for 30 min before treatment with or without TPA (30 nM). The luciferase activity was measured 12 h later. The data are expressed by mean ± SD from triplicate experiments. A Student's t-test was used to determine significant differences. Total RNA was isolated from cells at the time points as indicated. The mRNA expression of cyclophilin was used as the internal standard. Each value represents the mean ± SD of three to four separate experiments. To determine significant differences, Student's t-test was used. a P , 0.05 versus DMSO (6 h), b P , 0.05 versus TPA þ DMSO (6 h). (B) Cells were treated with DMSO or 13-HOA (40 lM) before treatment with or without TPA (30 nM) for 6 h. The data represent the mean ± SD of three separate experiments, and a representative picture is shown. A Student's t-test was used to determine significant differences. c P , 0.05 versus TPA þ DMSO (6 h). (C) Acetone or 13-HOA (1600 nmol) was applied to shaved dorsal skin of ICR mice. After 20 min, TPA (8 nmol) was applied to the same area. After 6 h, the mice were killed and epidermis of each mouse was collected. The expression of a-tubulin was used as the internal standard. Results are expressed as the mean ± SD of three experiments, and the picture is a representative of those experiments. Statistical analysis was done by Student's t-test.
d P , 0.05 versus TPA þ acetone.
Antitumor-promoting effects of linoleic acid metabolite whereas 13-HOA (1600 nmol) pretreatment 20 min before TPA treatment completely blocked it (P , 0.05).
Discussion
The functional link between inflammation and cancer has been supported by experimental results showing that tumor promotion occurs following exposure of cells to chemical irritants such as TPA, which is a strong inducer of inflammatory reactions (4) . In this study, we examined the anti-inflammatory and antitumor-promoting activities of 13-HOA using an assay of TPA-induced acute inflammation in mouse ears as well as a two-stage mouse skin carcinogenesis model. Our findings clearly indicated that 13-HOA, but not LA, significantly inhibited TPA-induced ear edema formation and mouse skin tumor promotion (Figures 2 and 3) . These results are partly supported by Ha et al. (29) , who also demonstrated that LA had no inhibitory effect on chemically induced mouse skin carcinogenesis. Meanwhile, a protein kinase C inhibitor, staurosporine, inhibited DMBA-teleocidin-induced skin cancer, whereas it promoted tumor formation in DMBA-initiated mouse skin in the absence of another tumor promoter (30) . In the present study, repetitive treatments with 13-HOA resulted in no tumors in DMBAinitiated mouse skin ( Figure 2 ) and 13-HOA did not increase the rate of spontaneous transformation in JB6 Pþ cells ( Figure 4A ), suggesting that 13-HOA does not act as a tumor promoter. Furthermore, our histological analyses revealed that 13-HOA significantly inhibited the infiltration of proinflammatory leukocytes ( Figure 3B ), which may have some relevance to our previous findings that 13-HOA markedly suppressed the expression of several proinflammatory mRNAs in LPSstimulated RAW 264.7 macrophages (18) and TPA-treated THP-1 monocytic cells (T.Nishizawa and A.Murakami, unpublished data).
It is notable that 13-HOA inhibited TPA-induced JB6 Pþ transformation in a concentration-dependent manner ( Figure 4A ), whereas LA had no effects. These results are consistent with those in the present ear inflammation ( Figure 2A ) and skin tumor promotion (Figure 2B-D) assays. 13-HOA (40 lM) and NS-398 (100 lM) abolished TPA-induced colony formation. That may be due to something other than cytotoxicity, since significant cell viability was maintained during the 24 h incubation period ( Figure 4A ). Liu et al. (31) reported that a dietary fatty acid, docosahexanoic acid, inhibited TPA-induced transformation of JB6 Pþ cells by $62% at a concentration of 60 lM, thus it is suggested that the suppressive potency of 13-HOA is greater than that of docosahexanoic acid.
Dhar et al. noted the MAPKs-AP-1 pathway is critical for TPAinduced transformation of JB6 Pþ cells, while in vivo results using dominant-negative c-Jun-expressing transgenic mice also revealed its importance (7, 32) . In addition, both fos-like region antigen (Fra-1) and JunD are essential components of the TPA-activated AP-1 complex, and ERK-dependent activation of Fra-1 is required for AP-1 transactivation in JB6 Pþ cells (33, 34) . On the other hand, our previous study demonstrated that 13-HOA inhibits the LPS-induced AP-1 transactivation and phosphorylation of ERK1/2 in RAW 264.7 cells (18), and in the present study, 13-HOA suppressed TPA-induced AP-1 transactivation as well ( Figure 4B ). To our surprise, however, 13-HOA did not inhibit, whereas NS-398, a selective cyclooxygenase-2 inhibitor, slightly activated TPA-induced ERK1/2 activation in JB6 Pþ cells ( Figure 4C ). Although it was previously reported that TPA activated c-Jun N-terminal kinase (JNK)1/2, p38 and c-Jun in JB6 Pþ cells (35) , analysis of time-course (TPA treatment for 1-12 h) phosphorylation of JNK1/2, p38 and c-Jun by western blotting did not reveal any detectable changes under the present experimental conditions, and 13-HOA had no effects on those (data not shown). Huang et al. (36) showed that dominant-negative JNK had no effect on TPAinduced colony formation by JB6 Pþ cells and Liu et al. (37) reported that AP-1 was activated through a molecular mechanism not associated with TPA-activated JNK1/2. Moreover, JNK activation is required for tumor necrosis factor-a but not TPA-induced transformation, whereas ERK activation plays an essential role in TPA-induced transformation of JB6 Pþ cells (36) . Based on our and these other results, it may be possible to rule out the possibility that suppression of JNK1/2, p38 and c-Jun is involved in the inhibitory mechanisms of transformation by 13-HOA.
There is a growing body of evidence that Pdcd4 has several key roles in antitumor promotion. Jansen et al. (13) reported that transgenic mice overexpressing Pdcd4 in the epidermis showed significant reductions in tumor promotion, whereas Yang et al. (12, 26) noted that an elevated expression of Pdcd4 inhibited tumor promotion of JB6 Pþ cells induced by TPA and tumorigenic JB6 RT101 (Tx) cells. In the present study, 13-HOA (40 lM) did not have an effect on ERK1/2 phosphorylation ( Figure 4C ), thus we hypothesized that 13-HOA may induce Pdcd4 expression resulting in inhibition of TPA-induced transformation in JB6 Pþ cells. Treatment of JB6 Pþ cells with 13-HOA (40 lM) induced pdcd4 mRNA expression in a transient manner ( Figure 5A ). NS-398 (100 lM) suppressed TPA-induced AP-1 activation but not ERK1/2 phosphorylation ( Figure 4B and C) , and Zhang et al. (14) reported that NS-398 induced pdcd4 mRNA using differential screening of colon carcinoma cells, whereas its effect was not remarkable with the JB6 Pþ cells in our study (data not shown). Although we examined pdcd4 mRNA inducibility using several food factors known to suppress tumor promotion in mouse skin (38) (39) (40) (41) , none showed significant effects on pdcd4 mRNA expression (data not shown). Pdcd4 protein was also induced by 13-HOA (40 lM and 1600 nmol) in JB6 Pþ cells and mouse skin treated with TPA, whereas TPA reduced Pdcd4 protein expression ( Figure 5B and C) . Recently, Matsuhashi et al. (42) showed an inverse correlation between PCNA expression and Pdcd4 expression in the human skin, and Yang et al. (27) reported that Pdcd4 inhibited extracellular matrix protease activity and cell migration in RKO human colon carcinoma cells. Thus, it might be possible that the induction of Pdcd4 by 13-HOA resulted in the inhibition of TPA-induced increases in leukocytes infiltration and PCNA ( Figure 3B-D) . Although the roles of Pdcd4 in inflammation are not clear, Pdcd4 inhibited constitutively or induced AP-1 activation (12), suggesting its potential for the prevention of inflammation in which AP-1 activation plays a major role. In fact, LPS reduced Pdcd4 expression in both mRNA and protein level in RAW 264.7 mouse macrophage (M.Yasuda and A.Murakami, unpublished data). Thus, it is probably that the inhibition by 13-HOA of TPA-induced ear inflammation may be associated with putative Pdcd4 induction. To our knowledge, this is the first report of a natural product being able to induce Pdcd4 expression. Lipoxin A, one of the lipoxygenase products of arachidonic acid, showed broad anti-inflammatory activities (43) and inhibited proliferation of human lung fibroblasts in experimental models of lung fibrosis (44) . In the latter report, Wu et al. reported that lipoxin A inhibited the proliferation of human lung fibroblasts via upregulation of p27 (Kip1). On the other hand, Ozpolat et al. (15) showed that knockdown of Pdcd4 by RNA interference downregulated p27 in acute myeloid leukemia cells. Therefore, it could be possible that lipoxin A might induce p27 through upregulation of Pdcd4.
Yang et al. reported that Fra-1-and JunD-induced AP-1 activation was inhibited by Pdcd4 expression in a concentration-dependent manner. Furthermore, Pdcd4 had no interaction with AP-1 proteins either directly or indirectly, thus it is considered to regulate a mediator that controls AP-1 transactivation in JB6 Pþ cells (12) . Identification of a still unknown Pdcd4-binding protein using a proteomics approach and analysis of the effects of 13-HOA on regulation of that protein are crucial for elucidating how 13-HOA inhibits TPA-induced AP-1 activity, as well as how induction of Pdcd4 by 13-HOA contributes to the suppression of neoplastic transformation. These issues are now under investigation and the results may be reported elsewhere.
Phosphatidylinositide 3-kinase/Akt/mammalian target of rapamycin pathway was reported to negatively regulate pdcd4 mRNA expression in human acute promyelocytic cells (15) , while the pdcd4 gene was previously detected as a target of the transcription factor v-myb myeloblastosis viral oncogene homolog (Myb) in a number of different hematopoietic avian cell lineages (45) . On the other hand, Pdcd4 translation was partially regulated by microRNA-21 (miR-21) in breast and colorectal cancer cells (46) , and AP-1 (c-Jun, JunB and Fra-1) induced miR-21 expression, followed by downregulation of Pdcd4 expression, which was included in a positive autoregulation loop with AP-1, miR-21 and Pdcd4 as a negative regulator of AP-1 in a rat thyroid cell system (47) . Furthermore, Chen et al. (48) hypothesized that Myb may be a target of miR-21. Also the stability of Pdcd4 protein is controlled by an ubiquitination-dependent mechanism associated with protein kinase C-dependent phosphatidylinositide 3-kinase/Akt/mammalian target of rapamycin and MEK-ERK pathways (49, 50) . Thus, the expression processes of Pdcd4 are regulated in a complicated multistep manner. Meanwhile, 13-HOA suppressed AP-1 activity in the present study ( Figure 4B ). Therefore, we consider that 13-HOA may negatively regulate miR-21 and positively regulate Myb in JB6 Pþ cells. Additional clarification of the molecular mechanisms involved in JB6 Pþ cells as well as other cell lines and examination of the role of 13-HOA with those mechanisms are necessary. Those are now in progress in our laboratory.
In conclusion, our results suggest that 13-HOA is a novel food factor with anti-inflammatory and chemopreventive properties. Since efficient separation and purification methods of 13-HOA have been established (17) , multiple evaluations of its cancer preventive efficacy may be feasible. It suppressed TPA-induced AP-1 activation but not ERK1/2 activation. Of interest, 13-HOA was found to induce the expression of the novel transformation suppressor Pdcd4 mRNA and protein both in vitro and in vivo. On the other hand, we could not clarify whether the inhibitory effects of 13-HOA on TPA-induced in vitro and in vivo activities are dependent on Pdcd4 induction. Additional studies are necessary to understand the action mechanisms of this unique fatty acid. 
